Page 7 - Industry Report

September quarter set for GST hiccups, analysts back HUL, Britannia, Marico

Heavy rains in Q2FY26 adversely affected seasonal categories such as carbonated drinks, ready-to-drink juices, beer, ice creams, and hair/skin summer care products.

Q2 results preview: Destocking prior to GST 2.0 may impact FMCG sales

FMCG companies face muted sales in July-September as distributors slow purchases ahead of GST-driven MRP cuts, with Hindustan Unilever citing a short-term impact

Cement prices to remain weak in coming qtrs despite demand: Elara Capital

Elara Capital cautions that the near-term pricing environment remains weak, with operating leverage and higher costs likely to weigh on profitability in Q2FY26 and potentially spill over into Q3FY26.

Auto sales set for strong September; analysts bet on Maruti, M&M, TVS Motor

September auto sales expectations: Analysts cite the start of festive sales from September 22, improved finance availability, dealer inventory build-up, and positive rural sentiment as key drivers.

Tariff uncertainties may spur rise in third-party pharma manufacturing

Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump's 100% tariff threat looms over patented drugs

Despite correction, gains unlikely for realty stocks in the near term

The key trigger for the sector and listed companies are trends in housing sales. Data on this front does not look favourable

Explained: Accenture Q4 beats estimates, but Indian IT outlook stays tepid

Accenture Q4FY25 results near top of guidance, but analysts remain cautious on Indian IT stocks amid macro uncertainty, weak discretionary spending, and H-1B risks

JM Fin bullish on PVC pipe cos; initiates coverage on Supreme Ind, Astral

The brokerage has initiated coverage on Astral and Supreme Industries, while re-initiating coverage on Prince Pipes & Fittings

Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded

Among individual counters, Sun Pharma slumped 4.87 per cent to a fresh 52-week low of ₹1,548, while Gland Pharma tumbled 4.70 per cent to ₹1,880. Biocon declined 3.68 per cent to ₹342.85.

ICICI, Axis, SBI: Nomura prefers large banks over small amid tariff jitters

Nomura's top picks in the current tariff scenario include ICICI Bank (Buy), State Bank of India (SBI) (Buy), and Axis Bank (Buy)

Motilal Oswal sees re-rating potential for PSU banks; SBI, PNB top bets

Despite a nearly 5x jump in aggregate mcap since FY20, most coverage PSBs still trade at reasonable valuations of 0.8-1x forward P/B & 5-7x FY27E EPS, leaving room for further upside.

India's software exports race ahead, but listed IT firms fall behind

India's software exports rose 12.7% in FY25, yet listed IT groups saw only 3.8% growth, with market share slipping as unlisted firms and GCCs expand faster

India's sugar sector sees sweet days ahead despite some bitter notes

The sugar season for 2025-26 promises to be bountiful, with a projected surplus of almost 12 million tonnes to be produced this season, raising hopes for both exports and ethanol

Nomura upbeat on steel sector; raises TP on JSW Steel, Jindal Stainless

The brokerage has raised its target on JSW Steel and Jindal Steel by 7 per cent and 6 per cent, respectively, projecting Ebitda CAGR) of 25-27 per cent during FY25-28F across its coverage universe

Motilal Oswal sector of the week: IT services; HCL Tech, Coforge top picks

Valuations across IT services are currently reasonable, but a sector-wide re-rating depends on the next tech cycle and earnings upgrades

IT firms brace for H-1B shock; Here's how brokerages assess the impact

On the bourses, the Nifty IT index is the worst-performing sector so far this year. The index is down 16 per cent in 2025

IT stocks brace for H-1B visa impact; but there's a silver lining: Analysts

Another silver lining for the companies and the markets, analysts said, is the falling dependence on the H-1B visa in the last few years.

Ambit turns bearish on CG Power, Siemens; ABB gets Buy call; here's why

Ambit warns of weak demand, global competition, and margin risks for CG Power, Siemens

Systematix bullish on PSBs; BoB, Union Bank may rise up to 30%: Here's why

Systematix noted that PSBs witnessed a remarkable turnaround in FY25, reversing the decade-long decline in their advances market share

Real estate stocks burn investor pockets in 2025; is rebound on the cards?

Real estate sector/stocks: The Nifty Realty index has slumped nearly 14 per cent so far in 2025 (till Sept 15), in sharp contrast to the 6 per cent gain in the benchmark Nifty50 index.